Estropipate

CAS No. 7280-37-7

Estropipate ( Piperazine Estrone Sulfate )

Catalog No. M15786 CAS No. 7280-37-7

Estropipate is a form of estrogen.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 37 In Stock
25MG 55 In Stock
50MG 77 In Stock
100MG 113 In Stock
200MG 147 In Stock
500MG 332 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Estropipate
  • Note
    Research use only, not for human use.
  • Brief Description
    Estropipate is a form of estrogen.
  • Description
    Estropipate is a form of estrogen. It has several uses such as: Alleviate symptoms of menopause as hormone replacement therapy, treatment some types of infertility, treatment of some conditions leading to underdevelopment of female sexual characteristics,treatment of vaginal atrophy,treatment of some types of breast Y (particularly in men and postmenopausal women), treatment of prostate Y and prevention of osteoporosis.
  • Synonyms
    Piperazine Estrone Sulfate
  • Pathway
    Endocrinology/Hormones
  • Target
    Estrogen Receptor/ERR
  • Recptor
    ER
  • Research Area
    Endocrinology
  • Indication
    ——

Chemical Information

  • CAS Number
    7280-37-7
  • Formula Weight
    436.56
  • Molecular Formula
    C22H32N2O5S
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 35mg/mL
  • SMILES
    C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O
  • Chemical Name
    [(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Brama M, et al. Mol Cell Endocrinol. 2007 Jan 29;264(1-2):102-8.
molnova catalog
related products
  • SAR439859

    SAR439859 is an orally active, nonsteroidal and selective degrader of estrogen receptor (SERD).

  • Endoxifen hydrochlor...

    A metabolite of tamoxifen, orally active non-steroidal selective estrogen receptor modulator (SERM) for the treatment of estrogen receptor-positive breast cancer.

  • GSK-4716

    GSK4716 is an ERRβ/γ agonist (IC50 = 2 μM) that can activate the receptor with similar potency as the protein ligand.